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Abstract
Background: The use of preference-based measures in the evaluation of health outcomes has
extended considerably over the last decade. Their alleged advantage over other types of general
instruments in the evaluation of health related quality of life (HRQOL), supposedly lies in the fact
that preference measures incorporate values or utilities that reflects the value of social preferences
through health states. The objective of this study was to determine whether the use of social
preference weights or utilities makes any real difference when calculating scores for the Euroqol
(EQ5-D) questionnaire, a HRQOL preference-based measure.
Methods: Responses to the EQ5-D of a sample of 10,972 patients from 10 countries enrolled in
an observational study of the treatment of schizophrenia in Europe were used for this purpose.
Two different methods of scoring the EQ-5D where compared: 'weighting the items' of the
questionnaire through the UK official weight coefficients, and 'non-weighting the items'. Pearson's,
Spearman's, and two-way mixed parametric intraclass correlation coefficients were used to
estimate the association of the scores obtained in both ways.
Results: The association between weighted and unweighted Euroqol scores was extremely high
(Pearson's r = 0.91), as was the association between their ranks (Spearman's ρ = 0.93). The
intraclass correlation coefficient obtained (0.89) also suggested that the concordance between the
score distributions was prominent.
Conclusions:  A non-weighted approach to score the EQ5-D is enough to explain a high
proportion of variance in scores obtained through the use of utilities. The differential contribution
of weights based on population preference values is therefore minimal and, in our opinion,
negligible.
Background
The use of preference-based measures in the evaluation of
health outcomes has extended considerably over the last
decade [1-4]. Their advantage over other types of general
instruments in the evaluation of health related quality of
life (HRQOL), such as the SF-36 [5], the Sickness Impact
Profile [6], and the Nottingham Health Profile [7], sup-
posedly lies in the fact that preference measures result in a
single numerical index that reflects the value of social
preferences through health states [8]. These numerical
indices are finally used to calculate the Quality Adjusted
Life Years (QALYs) [9] required to effect cost-utility stud-
ies [10] (cost-utility analysis is a form of economic evalu-
ation that focuses particular attention on the quality of the
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health outcomes produced by health programmes or
treatments) [11].
Broadly speaking, the preference-based approach assumes
that the social value or 'utility' of a health state is the same
as the value of the quality of life of those individuals who
are in it [12]. The value or utility of a health state is
expressed on a scale from 0 to 1, where 0 is the utility of
the state 'dead' and 1 is the utility of the state 'perfect
health'. The lower the quality of life associated with a
health state, the lower is its utility score on this scale [13].
Preference-based measures (or 'utility measures', as they
are normally called) [2] may take the form of multi-
attribute questionnaires [13]. Currently there are three
main multi-attribute questionnaires available: the Quality
of Well-Being (QWB) [14], the Health Utilities Index
(HUI) [15], and the EuroQol (EQ-5D) [16]. These ques-
tionnaires can be considered as simple classification sys-
tems based on the degree of limitation that individuals
indicate for different health dimensions, such as mobility,
pain, emotional aspects and social functioning. The
answers provided by the patients to each of these dimen-
sions allows the analyst to transform the scores – often
referred to as "health profiles" – into a single utility
number [13]. The transformation algorithms are based on
theoretical fundaments [17] and on previous research in
which one or more valuation techniques (i.e. Standard
Gamble (SG), Time Trade-Off (TTO), and Rating Scale
(RS)) [13] were used to measure directly the preferences of
individuals (usually from community surveys) for differ-
ent "health profiles".
Transformation algorithms basically consist of weighting
each of the answers provided to the items or classification
system domains, by means of a coefficient determined by
the social preferences obtained empirically by means of a
population sample. The final utility score is obtained
from a more or less complex combination of the resulting
weighted values. The description of the health state of a
subject may be summarised, in theory at least, as a health
index that reflects the social preferences of the population.
The alleged characteristics of the utility approach make it
quite attractive as a measure of HRQOL independent of its
usefulness in economic evaluation studies [8]. Utility
measures also provide a mechanism for making broad
comparisons across an array of clinical settings as well as
in the context of assessing population health quality [8].
Many studies have already used utility measures to quan-
tify the impact of interventions on HRQOL or to charac-
terise the severity profile of any health problem [1]. Even
the SF-36, which may be the paradigm of measures devel-
oped under a non-preference based approach, has been
tested for use as a utility measure [18].
Despite the relative merits of the theoretical arguments
made by proponents of the utility approach, in our opin-
ion the empirical issues concerning the assessment of
HRQOL through preference based measures remains
unresolved. The assumed advantage of weighting each
item individually is that valuations for all possible combi-
nations of single health descriptors, and thus all possible
health states, are elicited. Nevertheless, the crucial ques-
tion in seeking social preference weights for items is how
much difference it makes to use these differential weights
to calculate the composite utility score for a given health
state. As some authors have theorised, [19] it would make
a difference if the weighted and unweighted scores on the
multi-attribute questionnaire did not correlate highly. On
the evidence so far, the use of differential weights seldom
makes an important difference [20,21].
The aim of this study is to determine whether the use of
social preference weights or utilities makes any real differ-
ence when calculating scores in the preference-based meas-
ures in the evaluation of HRQOL.
Methods
In order to carry out this study, we chose one of the more
popular preference-weighted health state classification
questionnaires in Europe, the Euroqol [16]. The Euroqol
group has devoted considerable attention and effort to the
weighting of its items and has investigated a broad range
of modelling approaches for this purpose [22,23].
In order to test the usefulness of utilities in scoring the
EuroQol Descriptive system (EQ-5D), we developed a
parallel unweighted scoring rule solely based on patients'
answers to EQ-5D; in this way it is possible to determine
the value of any health state defined by the questionnaire
without having to use any type of social preference for the
items. We then compared the EQ-5D scores obtained
using the unweighted scoring rule with 'official' weighted
scores. These weights were determined on a random sam-
ple of the non-institutionalised adult population of the
United Kingdom [22].
The EQ-5D descriptive system
The instrument (see Table 1) contains a description of the
health state in 5 dimensions or items: Mobility, Self-care,
Usual activities, Pain/discomfort, and Anxiety/Depres-
sion. The items are always presented in the same order
and there are three levels of severity for each item: 1 (No
problems), 2 (Some problems) and 3 (Unable to do/
Extreme problems). For each item, the respondent must
indicate the level of severity that best describes his/her
personal health state at the time of giving the answers. The
subject's global health state is finally defined as the com-
bination of the level of problems described for each of the
five dimensions contained in the EQ-5D. The assemblageBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/10
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Table 1: EuroQol Descriptive system
Mobility
1. No problems walking
2. Some problems walking about
3. Confined to bed
Self-care
1. No problems with self-care
2. Some problems washing or dressing self
3. Unable to wash or dress self
Usual activities
1. No problems with performing usual activities (e.g. work, study, housework, family or leisure activities)
2. Some problems with performing usual activities
3. Unable to perform usual activities
Pain/discomfort
1. No pain or discomfort
2. Moderate pain or discomfort
3. Extreme pain or discomfort
Anxiety/depression
1. Not anxious or depressed
2. Moderately anxious or depressed
3. Extremely anxious or depressed
Each composite health state has a five digit code number relating to the response provided to each dimension. The composite state 22322, for 
example, corresponds to a subject who has some problem walking about (2), some problems washing or dressing self (2), is unable to perform usual 
activities (3), has moderate pain or discomfort (2), and is moderately anxious or depressed (2).
Table 2: EuroQol Scoring Formula based on UK Coefficients (Weights)
DIMENSION COEFFICIENT (Weight)
Constant 0.081
Mobility
Level 1 0
Level 2 0.069
Level 3 0.314
Self-care
Level 1 0
Level 2 0.104
Level 3 0.214
Usual activities
Level 1 0
Level 2 0.036
Level 3 0.094
Pain/discomfort
Level 1 0
Level 2 0.123
Level 3 0.386
Anxiety/depression
Level 1 0
Level 2 0.071
Level 3 0.236
N3 0.269
Scoring Formula EuroQol weighted scores are calculated by subtracting the relevant weight coefficients from 1 (Perfect health). The constant 
term is used if there is any item with a response greater than level 1. The N3 term is used if any item is at level 3. For example, the algorithm for 
computing the score for the health state 21223 is: 1 - (0.081 + 0.069 + 0 + 0.036 + 0.123 + 0.236 + 0.269) = 0.186BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/10
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of the 3 values for the 5 dimensions results in a five digit
number that classifies the subject in one of the 243 possi-
ble combinations (35 = 243). For example, health state
21223 corresponds to an individual who has some prob-
lem walking about, no problems with self-care, some
problems with performing usual activities, has moderate
pain or discomfort, and is extremely anxious or depressed.
It should be noted that the numerals have no arithmetic
properties and should not be used as a cardinal score.
Scoring weights for the EQ-5D descriptive system
Health states defined by the EQ-5D may be eventually
converted to a single summary or composite index by
applying scores from a standard set of values (or prefer-
ences) derived from general population samples [22].
Over the past few years, the EuroQol Group has been
engaged in several research projects exploring this issue.
Values have been elicited for different subsets of EQ-5D
health states from respondents in Canada, Denmark, Fin-
land, Germany, Japan, Netherlands, New Zealand, Slove-
nia, Spain, Sweden, UK, US and Zimbabwe.
The UK weights and scoring function for the EQ-5D are
depicted in detail in Table 2. Scores are calculated by sub-
tracting the relevant weight coefficients from 1 (Perfect
health). The constant term is used if there is any dysfunc-
tion at all (any item with a response greater than 1). The
N3 term is used if any item is at level 3. The weight for
each item is selected based on the level of response pro-
vided by the individual. The algorithm for computing the
score (or 'tariff', as referred to by some) is straightforward.
Table 2 shows the step by step procedure to obtain the
EQ5-D index score for the example described above,
where the respondent had the health state 21223. As it can
be seen, the resulting score for this particular health state
is: 0.186.
Unweighted scoring rule
In order to eliminate the possible influence that social
preferences may have on the EQ-5D index score, we devel-
oped an unweighted scoring rule based solely on answers
provided by subjects to the Descriptive system. Our pro-
posal consisted of assigning values 0, 1 and 2 to answer
options 1, 2 and 3, respectively (Table 3). Values 0, 1 and
2 represent the simplest option for scoring the EQ-5D as
if it were a non-preference based measure. The constant
and N3 terms were not considered for the calculation. As
in the case of the weighted scores, scores were calculated
by subtracting the sum of relevant unweighted coefficients
from 1. In this case, the sum of the coefficients must first
be divided by 10, in order to be able to express results on
a scale in which the value of 1 represents the level of per-
fect health. The resulting values are linearly transformed
to the same scale (min = -0.59, max = 1) as the weighted
Table 3: EuroQol Scoring Formula based on Unweighted Coefficients
DIMENSION COEFFICIENT (Unweighted)
Mobility
Level 1 0
Level 2 1
Level 3 2
Self-care
Level 1 0
Level 2 1
Level 3 2
Usual activities
Level 1 0
Level 2 1
Level 3 2
Pain/discomfort
Level 1 0
Level 2 1
Level 3 2
Anxiety/depression
Level 1 0
Level 2 1
Level 3 2
Scoring Formula The proposed unweighted scores are calculated by subtracting the sum of relevant unweighted coefficients, divided by 10, from 
1 (Perfect health). The resulting values are linearly transformed to the same scale (min = -0.59, max = 1) of the weighted scores by multiplying them 
for 1.59 (the range) and adding -0.59 (the lowest possible value). For example, the algorithm for computing the score for the health state 21223 is: 
[(1 - ((1 + 0 + 1 + 1 + 2)/10)] · 1.59 - 0.59 = 0.205BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/10
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scores by multiplying them by 1.59 (the range) and add-
ing -0.59 (the lowest possible value). In short, in order to
obtain the final index this unweighted scoring strategy
simply combines the answers provided by the subjects to
each of item of the questionnaire. Table 3 offers an exam-
ple in calculating the unweighted score for a health state
equivalent to 21223 described above. The resulting value
(0.205) shows a difference of 0.019 units in comparison
with the value obtained by means of weighted scoring of
items (0.186, Table 2). This difference accounts for just
over 1% of the whole possible range for the final score
(1.59).
The study sample
Considering that the objective of the study was to com-
pare the weighted and unweighted scores of the EQ-5D,
the analysis described below could be performed on any
sample of subjects answering the EQ-5D (results would be
invariant). In our case, and fundamentally for availability
reasons, we used answers to the EQ-5D of patients
included in an ongoing 3-year, prospective, observational
study of the treatment of schizophrenia in Europe. The
primary objective of the study is to assess the costs and
outcomes of antipsychotic treatment of schizophrenia
using antipsychotics. This study is being conducted in 10
European countries (Denmark, France, Germany, Greece,
Ireland, Italy, the Netherlands, Portugal, Spain and the
UK) A total of 10972 patients were enrolled. Baseline data
collection was conducted via a core data collection form
that included an self-administered version of the EQ-5D
Descriptive system. Details of the design of the study have
been presented elsewhere [24].
Comparison of preference-weighted and unweighted EQ-
5D scores
To assess the relevance of the social preference weights
(utilities) when analysing EQ-5D scores, the two different
methods of scoring the questionnaire, weighted and
unweighted, where compared.
Basic descriptive statistics of both score distributions were
provided. The comparison of the two scoring alternatives
was also performed through a paired design involving
weighted and unweighted scores: Spearman's (ρ), Pear-
son's (r) and two-way mixed parametric intraclass (ICC)
correlation coefficients were used to estimate the associa-
tion of the scores obtained in both ways. A graphical com-
parison approach (scatterplot) was additionally used to
illustrate the degree of association between the scores
obtained by the two methods. Analyses were done with
SPSS® for Windows®, v. 10.1.3.
Results
In the study, valid answers were obtained for all the items
in the questionnaire in a total of 9,991 patients.
Table 4 details the descriptive statistics associated with the
weighted and unweighted scores in the EQ-5D, and the
result of association tests between the two. The great sim-
ilarity in average scores obtained in both methods is of
particular note (0.50 and 0.56).
The correlation coefficient estimates were excellent (Table
4). The association between weighted and unweighted
EuroQol scores was extremely high (Pearson's r = 0.91), as
was the association between their ranks (Spearman's ρ =
0.93). The intraclass correlation coefficient obtained
(0.89) also suggests that, apart from a high association,
the concordance between the weighted and unweighted
score distributions was prominent.
The scatterplot in Figure 1 compares graphically the two
scoring strategies. The extent to which the points of the
scatterplot fall along a line reveals the degree of associa-
tion of the scoring options. Scatterplots are often a good
way of displaying data. Often, however, two or more
observations will have the same values on the variables
being graphed. When this happens, the points are
graphed on top of each other, and it cannot be told from
the scatterplot how many data points each symbol on the
Table 4: Descriptives and Measures of Association of Weighted and Unweighted EuroQol Scores.
Weighted Scores Unweighted Scores
Valid cases 9,991
Mean (95% CI) 0.56 (0.56–0.57) 0.50 (0.50–0.51)
SD 0.32 0.31
Minimum -0.59 -0.59
Maximum 1 1
Spearman's ρ 0.91*
Pearson's r 0.93*
ICC (95% CI) 0.89* (0.85–0.92)
P < 0.0001BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/10
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graph represents. In order to solve this problem, a small
line, called a petal, is added to each point on the scatter-
plot to indicate how many observations each point repre-
sents. In Figure 1 each petal symbolises 100 cases. As the
figure shows, all the points lie quite well along a line (R2
= 0.83), placing the weighted and unweighted scores close
enough to conclude that they are more than comparable.
Discussion
The results of this study reveal that a simple combination
of arbitrary values assigned to the items of the EQ5-D
Descriptive system is enough to explain a high proportion
of variance in scores obtained through the use of utilities.
The differential contribution of weights based on
population preference values is therefore minimal, and in
our opinion, negligible.
The supposed advantages obtained from the use of the
utility approach to measure HRQOL no longer stand if it
is possible to generalise these results. The EQ-5D, and
therefore, all preference based multi-attribute question-
naires supported by analogous scoring rules, would pro-
vide information that is conceptually comparable with
information from any non-preference based HRQOL
measure (such as the SF-36 or the Nottingham Health
Profile (NHP)). As in the case of the non-preference based
measures, scores obtained from evaluation of HRQOL
through preference-based measures are fundamentally a
direct reflection of the answers provided by the individu-
als to the items in the questionnaire. The results presented
here demonstrate, yet again, that weighting answers to the
items in the instruments does not imply a significant dif-
ference in the final score.
Scatterplot illustrating the degree of association between the weighted and the unweighted EuroQol scores Figure 1
Scatterplot illustrating the degree of association between the weighted and the unweighted EuroQol scores. A small line, called 
a petal, is added to each point on the scatterplot to indicate how many observations each point represents; each petal symbol-
izes 100 cases. Dotted lines mark the maximum and minimum limits of the scales, that is to say, the range of possible scores.
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Although this fact seriously questions the conceptual fun-
dament of evaluating HRQOL through preference meas-
ures, it does not necessarily jeopardise the validity or
reliability of results obtained through the use of such
instruments. In any event, it is still necessary to subject
results to the scrutiny of their basic psychometric proper-
ties through standard methods [19]
To the contrary of the argument put forward by Brazier
and Deverill in 1999 [25], our view is that the psychomet-
ric (read 'non-preference based') and economic
approaches (read 'preference based') are not different in
relation to conventional measurement criteria because
they seek to measure the same concepts. Both in prefer-
ence based measures and in non-preference based meas-
ures alike, primary interest lies in locating the responding
individuals at different points on a theoretical linear con-
tinuum representing possible levels of HRQOL. For this
purpose, total scores are computed by assuming that
point values assigned to each possible response to the
items form a numerical scale with the properties of order
and equal units. Item scoring weights might be assigned
by an arbitrary decision of the scale developer, but, as we
have already mentioned, this action seldom makes an
important difference. Thus, the sole purpose of preference
and non-preference based measures is to "scale" the sub-
jects based on their responses (weighted or not) to the
items. Torgerson called this scaling approach "Subject-
centred approach", where the systematic variation in the
reactions of the subjects to the items is attributed to indi-
vidual differences in the subjects [26]. The items, also
called "stimuli" in psychometric jargon, are considered as
replications: adding or deleting stimuli from the same
stimulus-population at random would have no effect on
procedure or results other than those due to the usual
sampling fluctuations [26].
What is indeed true is that the weights used in preference
based measures are obtained through a different scaling
approach. Torgerson called this "Stimulus-centred" or
"Judgement approach" [26]. In the "Stimulus-centred"
approach the immediate purpose of the assessment is to
scale the stimuli, which alone are assigned scale values.
Valuation techniques like SG, TTO and RS form part of
this modus operandi. The systematic variation in the reac-
tions of the subjects to the items or stimuli is attributed to
differences in the stimuli with respect to a designated
attribute. Adding subjects chosen at random from the
same population, or deleting subjects at random, would
have no effect on either the procedure or the results other
than the usual sampling fluctuations [26].
Although it is obvious that the weights used in preference
measures are taken from a Stimulus-centred scaling
approach, their action mechanism and the results they
provide are clearly defined as "Subject-centred".
In the light of the results presented in this study, we
believe that it is time to review the conceptual fundaments
related to the evaluation of HRQOL through preference
measures. Do these measures really differ from traditional
non-preference based measures? Does it make any sense
to go on using them? As Feeny argued in another context
[7], one reason for going on using preference based meas-
ures is that these instruments provide a single summary
score of outcomes that facilitate their interpretation and
integration of the same in formulae to calculate the cost-
effectiveness ratio in economic evaluations of health
interventions. Although this argument may be attractive at
first sight, it should not be accepted without further
thought. The single summary score produced by
preference based measures is the result of a simple combi-
nation of the different dimensions that are contained in
the instrument. In the case of the EQ-5D, this implies the
integration of dimensions such as anxiety/depression and
physical mobility, which may not initially appear to be
closely related, but may be combined for the purpose of a
common, second degree dimensionality that could be
called 'General Health'. But, if we permit the integration
of disparate dimensions in the EQ-5D, for example, then
why should we not permit it in other non-preference
based profile measures such as the SF-36? In fact, the
authors of the SF-36 have already empirically explored
this possibility [27].
Another reason for going on using preference based meas-
ures, also put forward by Feeny [7], is the integration of
the concept of mortality and morbidity in the scores for
these scales (in conventional utility scales the state of
being dead is assigned a score of 0 and perfect health is
assigned a score of 1). On this matter our view is more
radical: the scale produced by HRQOL preference based
measures is an interval scale, not a ratio scale; this means
that the numerical values assigned by the scale are totally
arbitrary, and 0 does not imply an 'absolute lack' of
HRQOL. The problem with the argument that HRQOL
does have a natural zero as death, is that there can be
states worse than death [28], and these states require a
score as well. In fact, to respond to this need, the score
algorithm of the EQ-5D assigns the value -0.59 to the
worst state of health possible when it uses the UK weights.
The integration of the concept of mortality is therefore a
fallacy, which is even more untenable considering the
marginal contribution of social preferences on the scores
of preference based measures like the EQ-5D.
Regardless of which theoretical arguments or personal
preferences are used for a given type of measure (prefer-
ence based versus non-preference based), the final out-BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/10
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come regarding the utility of preference based measures
must be a result of the evaluation of the quality of infor-
mation provided by the scores. The determination of the
reliability and validity of scores from this type of scales
using standardised methods is therefore absolutely
essential.
The results of this study also questions the multiple efforts
dedicated to obtaining specific national weighting for
instruments such as EQ-5D. Given the uselessness of util-
ities in scoring the EQ-5D, the only point in effecting this
type of activity is to obtain rankings or 'league tables' that
permit trans-cultural comparison of different health
states. In any event, we doubt that the high cost of such
effort is really worth it.
It is unquestionable that the concept of utility applied to
HRQOL evaluation has played a crucial role in the devel-
opment of a new discipline linked to the standardised
evaluation of the impact of health on the subjective per-
ception of individuals. The evaluation of HRQOL through
preference measures has permitted the concept of Quality-
Adjusted Life Year (QALY) to be extended as a measure of
the value of health outcomes. QALY, in turn, has allowed
the numerical representation of the value of health
through a single index combining individuals' quantity
and quality of life. This hallmark has been outstanding in
the definition of certain type of economic analyses (i.e.
Cost-Utility).
Conclusions
However, the findings in this study imply a new starting
point. Facts show that social preferences do not substan-
tially modify scores on scales that are simply calculated
from the combination of the answers provided to their
items. The supposed advantages of the preference based
measures in comparison with other less sophisticated
measures in health states are not so, and it is yet be deter-
mined what their differential use is, and whether it really
exists.
The debate on the convenience or otherwise of using
social preferences in the evaluation of health states is far
from being solved. In theory, in government-financed
health systems, social decisions are responsible for alloca-
tion of resources. However, the supposed objectivity of
social preference measures should not neglect the fact that
many conceptual, ethical and methodological problems
have yet to be solved, and the majority of instruments
used have not been designed for planning or allocation of
resources.
The patient is becoming the core of the health system. In
medicine there is now a concern for the measurement of
variables that interest the patient, and it is increasingly
important to have a good knowledge of the characteristics
of the same, in order to be able to individualise interven-
tions. Probably, optimised allocation of resources should
include the identification of all the patient's peculiarities,
including his/her own perception of health. In this con-
text, and with the limitations described earlier, we should
be asking ourselves what is the true value of society decid-
ing on the health states of individuals (this is not based on
conventional clinical variables, for example). Further-
more, if, as this study shows, social preferences do not
make any real difference to the scores provided by the
individuals themselves, then maybe this is the right
moment to leave the "stimulus-centred approach" to one
side, and to focus on the "subject-centred approach".
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